Takeda, Astellas, Dainippon Sumitomo Lead Japan Try For Cancer Drugs
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceuticals, Astellas Pharma and Dainippon Sumitomo Pharma are leading Japan drug makers with a new emphasis on beefing up research and development into cancer drugs.